Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people ...

K8 slowed disease progression and trended towards improving visual acuity, which Inflammasome says warrants the drug’s ...

Vonaprument reduced the proportion of eyes with clinically meaningful vision loss, though not uniformly across doses. Through ...

It’s a fine measure of the curator Joel Smith’s visual and emotional acuity that the first standout images one encounters on ...

Results point to potential to restore vision with drugs, non-invasively, reversibly, via a mechanism that is independent to ...

After a single intravitreal dose of 4D-150, visual acuity and anatomic control was maintained with consistent and durable treatment burden reduction through 2 years 4D-150 continues to be well tolerat ...

After a single intravitreal dose of 4D-150, visual acuity and anatomic control was maintained with consistent and durable treatment burden ...

In previous articles, I introduced retinal reserve as a framework for understanding the retina’s ability to maintain function ...

A tiny photovoltaic chip slipped beneath the retina gave most patients with advanced dry macular degeneration something they ...

Could a single border zone imaging measurement predict how quickly a geographic atrophy (GA) lesion will grow? A border zone ...

Dompé advances cenegermin-bkbj into Phase 3 for NAION, a rapid vision-loss condition with no FDA-approved treatment options.

New data presented at the American Academy of Ophthalmology highlights enhanced visual outcomes with next-generation LASIK technology ...